Aveanna director files to sell up to 46K shares
Rhea-AI Filing Summary
Aveanna Healthcare Holdings, Inc. (AVAH) director Erica G. Schwartz has filed a Rule 144 notice covering the potential sale of up to 46,071 shares of common stock on NASDAQ, with an aggregate market value of $644,994.00, based on an outstanding share count of 218,219,696 shares as of September 9, 2026.
The shares to be sold come from restricted stock granted by the issuer on February 14, 2026, July 22, 2026, and February 14, 2025. Schwartz also reports that during the prior three months she sold 230,343 shares of AVAH common stock for total proceeds of $3,224,802.00.
Positive
- None.
Negative
- None.
Key Figures
Shares proposed to be sold: 46,071 shares
Aggregate market value of proposed sale: $644,994.00
Shares outstanding: 218,219,696 shares
+5 more
8 metrics
Shares proposed to be sold
46,071 shares
Aveanna common stock covered by the Rule 144 notice
Aggregate market value of proposed sale
$644,994.00
Value of 46,071 Aveanna shares referenced in the notice
Shares outstanding
218,219,696 shares
Aveanna common stock outstanding as referenced with date September 9, 2026
Shares sold in past 3 months
230,343 shares
Aveanna common stock sold on August 27, 2026
Proceeds from past 3 months’ sales
$3,224,802.00
Total consideration for 230,343 Aveanna shares sold on August 27, 2026
Restricted stock tranche 1
23,584 shares
Restricted Aveanna common stock dated February 14, 2026
Restricted stock tranche 2
18,916 shares
Restricted Aveanna common stock dated July 22, 2026
Restricted stock tranche 3
3,571 shares
Restricted Aveanna common stock dated February 14, 2025
Key Terms
Rule 144, Restricted Stock, aggregate market value
3 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Restricted Stock financial
"Common | 02/14/2026 | Restricted Stock | Issuer"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
aggregate market value financial
"Common | Morgan Stanley Smith Barney LLC ... | 46071 | 644994.00"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
FAQ
What does Aveanna Healthcare (AVAH) director Erica G. Schwartz plan to sell under this Form 144?
Erica G. Schwartz filed to potentially sell up to 46,071 shares of Aveanna Healthcare Holdings, Inc. common stock under Rule 144, with an aggregate market value of $644,994.00 based on information dated September 9, 2026.
What is the recent selling history disclosed for AVAH in this Form 144?
The filing states that during the past three months, 230,343 shares of Aveanna common stock were sold for total consideration of $3,224,802.00 in a transaction dated August 27, 2026.
What types of AVAH securities are being sold under this Form 144?
All securities listed are Aveanna common stock derived from Restricted Stock granted by the issuer on February 14, 2026, July 22, 2026, and February 14, 2025.
AI-generated analysis. How Rhea-AI works. Not financial advice.